CAB LA PrEP Cohort: Prospective Cohort Study to Assess Adherence and Effectiveness of, and Monitor for Hepatotoxicity and Resistance to, Cabotegravir for Pre-Exposure Prophylaxis in Europe (221935)

First published 22/08/2024

Last updated 11/11/2024

EU PAS number:

EUPAS1000000299

Study

Ongoing

Documents

Study protocol

Initial protocol

221935_NEAT ID_CAB LA PrEP Cohort Study in Europe_Final Protocol Anonymised 12 Aug 2024.pdf

English (1.13 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs